Biosimilars in the Treatment of Rheumatic Diseases: Pro Et Contra

Clinical pharmacology and therapy
doi 10.32756/0869-5490-2019-4-50-55
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmapress LLC

Related search

The Role of Biosimilars in the Treatment of Rheumatic Diseases

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2012English

The Role of Biosimilars in the Treatment of Rheumatic Diseases

Clinical pharmacology and therapy
2018English

Viešoji Sociologija Lietuvoje: Pro Et Contra

Sociologija. Mintis ir veiksmas
2009English

Plan and Market in the Economic History of Russia: Pro Et Contra

Bulletin of the Moscow State Regional University (Economics)
2017English

Biosimilars in Gastroenterology- An Important Moment in the Treatment of Inflammatory Bowel Diseases

International Journal of Gastroenterology Disorders & Therapy
2016English

The Concept of the Civil Religion of Robert Bellah: Pro Et Contra

Sociological studios
2018English

Diclofenac in the Treatment of Pain in Patients With Rheumatic Diseases

Reumatologia
RheumatologyAllergyImmunology
2018English

Chronic Rheumatic Diseases. Their Diagnosis and Treatment

American Journal of the Medical Sciences
Medicine
1927English

Immunology in the Rheumatic Diseases

BMJ
1960English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy